Correlation between voiding and erectile function in patients with symptomatic benign prostatic hyperplasia

Journal of the Chinese Medical Association

Volumn 68, Issue 4, 2005, Pages 178-182

  Huang, Wei Jung ^a   Chen, Kuang Kuo ^a,b   Chang, Luke S ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Aging; American Urological Association Symptom Index; Benign prostatic hyperplasia; Erectile dysfunction; International Index of Erectile Function

Indexed keywords

DOXAZOSIN; FINASTERIDE; TAMSULOSIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLADDER IRRITATION; BLADDER OBSTRUCTION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; ERECTILE DYSFUNCTION; HUMAN; MALE; MALE SEXUAL DYSFUNCTION; MICTURITION DISORDER; ORGASM; PENIS ERECTION; PROSTATE HYPERTROPHY; QUESTIONNAIRE; SATISFACTION; SCORING SYSTEM; SELF REPORT; SEXUAL AROUSAL; SEXUAL INTERCOURSE; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY; URINARY TRACT DISEASE;

EID: 17244366778     PISSN: 17264901     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1726-4901(09)70245-X     Document Type: Article

References (27)

1. Garraway WM, Collins GN, Lee RJ. High prevalence of benign prostatic hypertrophy in the community. Lancet 1991;338: 469-71.
2. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994;151:54-61.
3. Kassabian VS. Sexual function in patients treated for benign prostatic hyperplasia. Lancet 2003;361:60-2.
4. Frankel SJ, Donovan JL, Peters TI, Abrams P, Dabhoiwala NF, Osawa D, Lin AT. Sexual dysfunction in men with lower urinary tract symptoms. J Clin Epidemiol 1998;51:677-85.
5. Baniel J, Israilov S, Shrmueli J, Segenreich E, Livne PM. Sexual function in 131 patients with benign prostatic hyperplasia before prostatectomy. Eur Urol 2000;38:53-8.
6. Tubaro A, Polito M, Giambroni L, Famulari C, Gange E, Ostardo E. Sexual function in patients with LUTS suggestive of BPH. Eur Urol 2001;40:19-22.
7. Janus SS, Janus CL. The Janus report on sexual behavior New York: John Wiley & Sons, 1993:25-90.
8. Vale J. Benign prostatic hyperplasia and erectile dysfunction - is there a link? Curr Med Res Opin 2000;16:67.
9. Cockett AT, Aso Y, Denis L, Khoury S, Barry M, Carlton CE, Coffey D, et al. World Health Organization Consensus Committee recommendations concerning the diagnosis of BPH. Prog Urol 1991;1:957-72.
10. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997;49:822-30.
11. NIH Consensus Development Panel on Impotence: Impotence. JAMA 1993;270:83-90.
12. Cappelleri JC, Rosen RC, Smith MD, Mishra A, Osterloh IH. Diagnostic evaluation of the erectile function domain of the international index of erectile function. Urology 1999;54: 346-51.
13. Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol 1984; 132:474-9.
14. Wasson JH, Reda DJ, Bruskewitz RC, Elinson J, Keller AM, Henderson WG. A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. The Veterans Affairs Cooperative Study Group on Transurethral Resection of the Prostate. N Engl J Med 1995; 332:75-9.
15. McConnell JD, Bruskewitz B, Walsh P, Andriole G, Lieber M, Holtgrewe HL, Albertsen P, et al. The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride Long-Term Efficacy Safety Study Group. N Engl J Med 1998;338:557-63.
16. Goldstein I, Lue T, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA. Oral sildenafil in the treatment of erectile dysfunction. N Engl J Med 1998;338:1397-404.
17. Johannes CB, Araujo AB, Feldman HA, Derby CA, Kleinman KP, McKinlay JB. Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts Male Aging Study. J Urol 2000;163:460-3.
18. Koskimäki J, Hakama M, Huhtala H, Tammela TLJ. Association of LUTS with erectile dysfunction. Eur Urol 1999;35:116.
19. Leliefeld HHJ, Stovelaar HJ, McDonell J. Sexual function before and after various treatments for symptomatic benign prostatic hyperplasia. BJU Int 2002;89:208-13.
20. Richard F, Lukacs B, Jardin A, Lanson Y, Chevret-Measson M, Grange JC, Navratil H. Results of an epidemiologic surgery carried out with men 50-80 years of age to study urinary disorders, quality of life and sexual function. Prog Urol 2001; 11:250-63. [In French]
21. Sairam K, Kulinskaya E, McNicholas TA, Boustead GB, Hanbury DC. Sildenafil influences lower urinary tract symptoms. BJU Int 2002;90:836-9.
22. Barry MJ, Fowler FJ Jr, O'Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK. Measuring disease-specific health status in men with benign prostatic hyperplasia. Measurement Committee of the American Urological Association. Med Care 1995;33:145-55.
23. Moulik PK, Hardy KJ. Hypertension, anti-hypertensive drug therapy and erectile dysfunction in diabetes. Diabet Med 2003; 20:290-3.
24. Morley JE, Kaiser FE. Sexual function with advancing age. Med Clin N Am 1989;73:1483-95.
25. Downs TM, O'Leary MP. Sexual dysfunction in patients with benign prostatic hyperplasia. Curr Opin Urol 1999;9:9-14.
26. Diokno AC, Brown MB, Herzog AR. Sexual function in the elderly. Arch Intern Med 1990;150:197-200.
27. Chang SC, Chen KK, Chang LS. Evaluation of erectile dysfunction using the International Index of Erectile Function-5 (IIEF-5) in 200 urological patients. J Urol ROC 2000;11: 108-13.